MARKET WIRE NEWS
  1. Home
  2. Stock
  3. IOVA
  4. News
IOVA
Quote
Short
News
Articles
Message Board

Iovance Biotherapeutics Inc. (NASDAQ : IOVA ) News

News Releases

IOVA News Releases
IOVA : NASDAQ
Motley Fool
This Stock Is Up 74% This Year: Is It Too Late to Buy?
IOVA : NASDAQ
Motley Fool
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
IOVA : NASDAQ
SeekingAlpha
Replimune: Stock Buoyant On Third Try At RP1 Approval - FDA AdCom May Be Crucial
IOVA : NASDAQ
Motley Fool
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
IOVA : NASDAQ
SeekingAlpha
Iovance Biotherapeutics: Commercial, Clinical And Regulatory Tailwinds
IOVA : NASDAQ
SeekingAlpha
Iovance Biotherapeutics: Progress With Caveats
IOVA : NASDAQ
GlobeNewswire
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
IOVA : NASDAQ
SeekingAlpha
Iovance rises as Australia approves melanoma therapy Amtagvi
IOVA : NASDAQ
GlobeNewswire
Iovance's Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia
IOVA : NASDAQ
Motley Fool
Iovance Stock Has Been Hammered. Is This the Buying Opportunity Aggressive Investors Have Been Waiting For?
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.